Follow Us

Dr Siyamol Mingmalairak

Specialty
  • Medicine
  • Sub-specialty
  • Oncology
  • Diagnosis, Planning and Systematic therapy for Solid Cancer Chemotherapy, Targeted Therapy, and Immunotherapy
    Sun
    08.00-12.00
    Mon
    08.00-17.00
    Tue
    -
    Wed
    08.00-17.00
    Thu
    08.00-17.00
    Fri
    08.00-17.00
    Sat
    -
    Specialty
  • Medicine
  • Sub-specialty
  • Oncology
  • Diagnosis, Planning and Systematic therapy for Solid Cancer Chemotherapy, Targeted Therapy, and Immunotherapy
    Sun
    08.00-12.00
    Mon
    08.00-17.00
    Tue
    -
    Wed
    08.00-17.00
    Thu
    08.00-17.00
    Fri
    08.00-17.00
    Sat
    -
    Time Table
    Sun
    08.00-12.00
    Mon
    08.00-17.00
    Tue
    -
    Wed
    08.00-17.00
    Thu
    08.00-17.00
    Fri
    08.00-17.00
    Sat
    -
    Treatments & Services
    • Diagnosis, Planning and Systematic therapy for Solid Cancer
    • Chemotherapy, Targeted Therapy, and Immunotherapy
    • Palliative Care Service
    Education & Achievements

    2015 – Fellowship in Medical Oncology Department of Internal Medicine, Chulalongkorn University

    2015 – Master Degree of Science,
    Chulalongkorn University, Thailand

    2005 – Residency – Department of Internal Medicine, Chulalongkorn University

    1999 – Doctor of Medicine
    Faculty of Medicine, Chulalongkorn University, Thailand

    1994 – Bachelor Degree of Science (Second Class Honor), Biochemistry Department, Faculty of Science, Chulalongkorn University, Thailand

    Certification

    2011 – Thai Board of Medical Oncology

    2005 – Higher Diploma in clinical science in internal medicine

    2005 – Thai Board of Internal Medicine

    2003 – Diploma in clinical science in internal medicine

    Research & Publications

    Mingmalairak S , Soonrhornyothin S.Endocrine abnormalities in AIDS patients . Chula Med J 2006;19(2): 53-62

    Vinayanuwattikun C, Mingmalairak S, Jittapiromsak N Thaipisuttikul I, Sriuranpong V, Mutirangura A. , Shuangshoti S. SHP-1 promotmeniger 2 methylation in cerebrospinal fluid for diagnosis of leptomeningeal epithelial-derived malignancy ( carcinamatous meningitis ) J Neurooncol.Sep;129 (3): 395-403